Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Titan Pharmaceuticals Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 22 | 24 | +2 |
| Shares | 386.9K | 419.1K | +32.2K (+8.3%) |
| Value | $722.0K | $430.0K | −$292.0K (−40.4%) |
New holders (9)
Institutions that held Titan Pharmaceuticals Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 38,930 | $40.0K | 0.00% |
| Millennium Management LLC | 20,175 | $21.0K | 0.00% |
| Virtu Financial LLC | 15,422 | $16.0K | 0.00% |
| Winning Points Advisors, LLC | 11,685 | $15.0K | 0.01% |
| Simplex Trading, LLC | 3,806 | $3.00K | 0.00% |
| Level Financial Advisors, Inc. | 987 | $1.00K | 0.00% |
| Newbridge Financial Services Group, Inc. | 2 | $0 | 0.00% |
| Widmann Financial Services, Inc. | 1 | $0 | 0.00% |
| Fortitude Advisory Group L.L.C. | 8 | $0 | 0.00% |
Sold out (7)
Institutions that held Titan Pharmaceuticals Inc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Trust Co | 1 | $1.00K |
| JPMorgan Chase & Co | 8 | $0 |
| Lee Financial Co | 6 | $0 |
| Benjamin Edwards Inc | 2 | $0 |
| Sargent Bickham Lagudis LLC | 2 | $0 |
| Joseph P. Lucia & Associates, LLC | 2 | $0 |
| Pacifica Partners Inc. | 6 | $0 |